CLINICAL_TRIALS
trial_result
· 2012-09-14
Clinical Trial Update: A Study to Compare the Safety and Tolerability of Sativex® in Patients With Neuropathic Pain. [Phase 3]
Summary
A Phase 3 trial assessing the safety and tolerability of Sativex in patients with neuropathic pain has completed, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jazz Pharmaceuticals | Conditions: Pain, Peripheral Neuropathy | Phase 3 | Status: COMPLETED | Results posted: 2012-09-14